BiotechTube
Home/Cellastra/Karl L Mettinger, MD, PhD
KL

Karl L Mettinger, MD, PhD

Co-founder, Interim Chair, President & CEO

Cellastra

Therapeutic Areas

Pulmonary FibrosisBurn InjuriesSurgical AdhesionsTraumatic Brain Injury

Cellastra Pipeline

DrugIndicationPhase
Anti-Scarring Gene Therapy PlatformPulmonary Fibrosis/Infections, Burn Injuries, Surgical Adhesions, Traumatic Brain InjuryPre-clinical

Leadership Team at Cellastra

VK
Vinod Kumar, MD
EVP, Chief Medical Officer
H(
Henrik (Hank) Kulmala, PhD
EVP Regulatory/Product Development
View full Cellastra profile